跳至主要内容
临床试验/NCT03579212
NCT03579212终止不适用

National, Multicentre, Prospective, Retrospective, Observational Study, to Evaluate the Performance of Y-STRUT® Medical Device to Strengthen Pre-fractural Tumour-induced Lesions at the Level of the Proximal Femur

Hyprevention4 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Hyprevention
入组人数
16
试验地点
4
主要终点
Frequency of post-operative fracture [Performance of the device]

研究概览

简要总结

HIPPON 100 is a national, multicentre, prospective, retrospective, descriptive and non-interventional study, in patients having a Y-STRUT® medical device implanted to prevent a high risk of impending pathological fracture.

The primary objective of this study is to evaluate the performance of the studied medical device by measuring the frequency of patient with a fracture at the implantation site within 1 year after implantation.

A total of 100 patients from France will be enrolled (until November 2018) and followed up to 24 months.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient ≥ 18 years old
  • Patient with information form signed to participate in the study;
  • Patient presenting a cancer with bone metastases at the level of the proximal femur and having a Y-STRUT® medical device implanted;
  • Patient able to complete a questionnaire.

排除标准

  • Patient who refuse to participate to this study;
  • Patient already enrolled in a clinical study, excluding his participation to HIPPON100.

结局指标

主要结局

Frequency of post-operative fracture [Performance of the device]

时间窗: At 12 months

Frequency of patient with a fracture at the implantation site

次要结局

  • Quality of life [Tolerance of the device](pre-operative, immediate post-op, and at 6, 12 and 24 months)
  • Hospitalisation duration [feasibility of the procedure](At inclusion (day 1))
  • Frequency of post-operative fracture [Performance of the device](At 6 and 24 months)
  • Rates of complications [feasibility of the procedure](At inclusion (day 1))
  • Pain [Tolerance of the device](immediate post-op, and at 6, 12 and 24 months)
  • Surgical procedure duration [feasibility of the procedure](At inclusion (day 1))
  • Resumption of weight-bearing [Tolerance of the device](immediate post-op, and at 6, 12 and 24 months)
  • Recording of adverse events and device effects [Safety of the device](At 6, 12 and 24 months)
  • Calculation of associated costs [Economic impact of the procedure](At the end of the study (24 months from the last included patient))

研究者

发起方
Hyprevention
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验